bpc-157 therapeutic uses Sample of patents with BPC 157 utilization BPC-157 Peptide Therapy - Medical
Description
Approximately one year later, he experienced a severe worsening of his previously very mild neuropathy, and lab evaluation yielded a serum B12 of 220 pmol/l (which is normal, remember!?), but an elevated serum MMA of 1300 nmol/l, supporting the existence of true B12 deficiency

Because a pharmaceutical company cant monetize it because theres no patent on it, so I dont know when were ever going to get the real truth on this thing, because nobodys putting billions of dollars into researching it, because nobodys going to monetize it

ACS Chemical Neuroscience 14 (4): 527553

Researcher FAQ How do I reconstitute this peptide
